Tapewire

NYSE · USD

JNJ

JOHNSON & JOHNSON

Export transactions ↓
Tapewire entity
2722
SEC CIK
0000200406
Parsed reports
1,771

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202602
Feb 2026015
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 04, 2025 Filed Mar 13, 2026 01:31 UTC GrantDeferred Share Units · Derivative 75.256 $166.10 $12,500.02
Disclosure

SEC source: 0000200406-26-000070 · wk-form4_1773365486.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,306.4487

Underlying: Common Stock · 75.256 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 23:42 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 6,999 $101.87 Strike: $101.87 $712,988.13
Disclosure

SEC source: 0000200406-25-000086 · wk-form4_1740613359.xml · derivative · entry 5

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,999 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Vested and exercisable on the third anniversary of the date of the grant.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 23:42 UTC
Decker Robert JVP Corporate Controller
SaleCommon Stock 6,999 $165.88 $1,160,994.12
Disclosure

SEC source: 0000200406-25-000086 · wk-form4_1740613359.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,001

F1 · price: This transaction was executed in multiple trades at prices ranging from $165.88 to $165.895. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 23:42 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionCommon Stock 6,999 $101.87 $712,988.13
Disclosure

SEC source: 0000200406-25-000086 · wk-form4_1740613359.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 01:58 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Tax withholdingCommon Stock 158 $156.15 $24,671.70
Disclosure

SEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · nonDerivative · entry 6

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,681

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:01 UTC
Decker Robert JVP Corporate Controller
Tax withholdingCommon Stock 94 $156.15 $14,678.10
Disclosure

SEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · nonDerivative · entry 6

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,022

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:02 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Tax withholdingCommon Stock 1,602 $156.15 $250,152.30
Disclosure

SEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · nonDerivative · entry 6

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,923

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:03 UTC
Forminard ElizabethExecutive VP, General Counsel
Tax withholdingCommon Stock 307 $156.15 $47,938.05
Disclosure

SEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · nonDerivative · entry 6

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,014

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:05 UTC
Mulholland KristenEVP, Chief HR Officer
Tax withholdingCommon Stock 120 $156.15 $18,738.00
Disclosure

SEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · nonDerivative · entry 6

Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,975

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:06 UTC Tax withholdingCommon Stock 141 $156.15 $22,017.15
Disclosure

SEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · nonDerivative · entry 6

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,620.59

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:08 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
Tax withholdingCommon Stock 651 $156.15 $101,653.65
Disclosure

SEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 6

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,459.001

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:11 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Tax withholdingCommon Stock 385 $156.15 $60,117.75
Disclosure

SEC source: 0000200406-25-000054 · wk-form4_1739931099.xml · nonDerivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,542

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:13 UTC
Wolk Joseph JExec VP, CFO
Tax withholdingCommon Stock 768 $156.15 $119,923.20
Disclosure

SEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 6

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,345

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:16 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
Tax withholdingCommon Stock 200 $156.15 $31,230.00
Disclosure

SEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 6

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,836.8735

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 18, 2025 Filed Feb 19, 2025 02:33 UTC
Schmid TimothyEVP, WW Chair, MedTech
SaleCommon Stock 403 $156.15 $62,928.45
Disclosure

SEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 6

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,098

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 01:58 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionRestricted Share Units · Derivative 492 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · derivative · entry 12

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 983

Underlying: Common Stock · 492 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 01:58 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionCommon Stock 492 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · nonDerivative · entry 5

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:01 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionRestricted Share Units · Derivative 339 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · derivative · entry 13

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 677

Underlying: Common Stock · 339 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:01 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionCommon Stock 339 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · nonDerivative · entry 5

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,116

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:02 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionRestricted Share Units · Derivative 3,682 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · derivative · entry 12

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,364

Underlying: Common Stock · 3,682 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:02 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionCommon Stock 3,682 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · nonDerivative · entry 5

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 397,525

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:03 UTC
Forminard ElizabethExecutive VP, General Counsel
Exercise / conversionRestricted Share Units · Derivative 961 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · derivative · entry 11

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,922

Underlying: Common Stock · 961 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:03 UTC
Forminard ElizabethExecutive VP, General Counsel
Exercise / conversionCommon Stock 961 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · nonDerivative · entry 5

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:05 UTC
Mulholland KristenEVP, Chief HR Officer
Exercise / conversionRestricted Share Units · Derivative 419 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · derivative · entry 11

Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 837

Underlying: Common Stock · 419 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:05 UTC
Mulholland KristenEVP, Chief HR Officer
Exercise / conversionCommon Stock 419 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · nonDerivative · entry 5

Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:06 UTC Exercise / conversionRestricted Share Units · Derivative 492 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · derivative · entry 11

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 983

Underlying: Common Stock · 492 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:06 UTC Exercise / conversionCommon Stock 492 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · nonDerivative · entry 5

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,761.59

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:08 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
Exercise / conversionRestricted Share Units · Derivative 1,594 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · derivative · entry 11

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,188

Underlying: Common Stock · 1,594 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:08 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
Exercise / conversionCommon Stock 1,594 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 5

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,110.001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:11 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionRestricted Share Units · Derivative 1,350 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000054 · wk-form4_1739931099.xml · derivative · entry 3

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,698

Underlying: Common Stock · 1,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F3 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:11 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionCommon Stock 1,350 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000054 · wk-form4_1739931099.xml · nonDerivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:13 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionRestricted Share Units · Derivative 1,971 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · derivative · entry 13

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,942

Underlying: Common Stock · 1,971 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:13 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionCommon Stock 1,971 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 5

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,113

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:16 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
Exercise / conversionRestricted Share Units · Derivative 607 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · derivative · entry 13

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,212

Underlying: Common Stock · 607 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:16 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
Exercise / conversionCommon Stock 607 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 5

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,036.8735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:33 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionRestricted Share Units · Derivative 1,029 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · derivative · entry 9

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,056

Underlying: Common Stock · 1,029 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F5 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 02:33 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionCommon Stock 1,029 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 5

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:16 UTC
Broadhurst VanessaEVP, Global Corp Affairs
GrantRestricted Share Units · Derivative 1,576 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000064 · wk-form4_1740003385.xml · derivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,576

Underlying: Common Stock · 1,576 shares

Expires not disclosed

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:16 UTC
Broadhurst VanessaEVP, Global Corp Affairs
GrantEmployee Stock Options (Right to Buy) · Derivative 25,538 $0.00 Strike: $156.15 $0.00
Disclosure

SEC source: 0000200406-25-000064 · wk-form4_1740003385.xml · derivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,538

Underlying: Common Stock · 25,538 shares

Expires 2035-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:18 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
GrantRestricted Share Units · Derivative 13,513 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000066 · wk-form4_1740003520.xml · derivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,513

Underlying: Common Stock · 13,513 shares

Expires not disclosed

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:18 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
GrantEmployee Stock Options (Right to Buy) · Derivative 219,020 $0.00 Strike: $156.15 $0.00
Disclosure

SEC source: 0000200406-25-000066 · wk-form4_1740003520.xml · derivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,020

Underlying: Common Stock · 219,020 shares

Expires 2035-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:22 UTC
Decker Robert JVP Corporate Controller
GrantRestricted Share Units · Derivative 1,031 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000068 · wk-form4_1740003766.xml · derivative · entry 2

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,031

Underlying: Common Stock · 1,031 shares

Expires not disclosed

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:22 UTC
Decker Robert JVP Corporate Controller
GrantEmployee Stock Options (Right to Buy) · Derivative 8,357 $0.00 Strike: $156.15 $0.00
Disclosure

SEC source: 0000200406-25-000068 · wk-form4_1740003766.xml · derivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,357

Underlying: Common Stock · 8,357 shares

Expires 2035-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:25 UTC
Forminard ElizabethExecutive VP, General Counsel
GrantRestricted Share Units · Derivative 3,189 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000070 · wk-form4_1740003921.xml · derivative · entry 2

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,189

Underlying: Common Stock · 3,189 shares

Expires not disclosed

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:25 UTC
Forminard ElizabethExecutive VP, General Counsel
GrantEmployee Stock Options (Right to Buy) · Derivative 51,688 $0.00 Strike: $156.15 $0.00
Disclosure

SEC source: 0000200406-25-000070 · wk-form4_1740003921.xml · derivative · entry 1

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,688

Underlying: Common Stock · 51,688 shares

Expires 2035-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:27 UTC
Mulholland KristenEVP, Chief HR Officer
GrantRestricted Share Units · Derivative 1,725 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000072 · wk-form4_1740004038.xml · derivative · entry 2

Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,725

Underlying: Common Stock · 1,725 shares

Expires not disclosed

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:27 UTC
Mulholland KristenEVP, Chief HR Officer
GrantEmployee Stock Options (Right to Buy) · Derivative 27,951 $0.00 Strike: $156.15 $0.00
Disclosure

SEC source: 0000200406-25-000072 · wk-form4_1740004038.xml · derivative · entry 1

Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,951

Underlying: Common Stock · 27,951 shares

Expires 2035-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:29 UTC
REED JOHN CEVP, Innovative Medicine, R&D
GrantRestricted Share Units · Derivative 5,539 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000074 · wk-form4_1740004157.xml · derivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,539

Underlying: Common Stock · 5,539 shares

Expires not disclosed

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:29 UTC
REED JOHN CEVP, Innovative Medicine, R&D
GrantEmployee Stock Options (Right to Buy) · Derivative 89,781 $0.00 Strike: $156.15 $0.00
Disclosure

SEC source: 0000200406-25-000074 · wk-form4_1740004157.xml · derivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,781

Underlying: Common Stock · 89,781 shares

Expires 2035-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 22:31 UTC
Schmid TimothyEVP, WW Chair, MedTech
GrantRestricted Share Units · Derivative 3,077 $0.00 $0.00
Disclosure

SEC source: 0000200406-25-000076 · wk-form4_1740004292.xml · derivative · entry 2

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,077

Underlying: Common Stock · 3,077 shares

Expires not disclosed

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.